Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Regulatory News (AGL)

  • There is currently no data for AGL

Rule 8.3- Angle Plc

19 Jun 2008 11:37

RNS Number : 0870X
Henderson Global Investors Ltd
19 June 2008
 

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

Henderson Global Investors Ltd

Company dealt in

Angle

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORD GBP0.10

Date of dealing

18/06/08

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

 

Number 

(%)

Number

(%)

(1) Relevant securities 

295,000

1.0872

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

295,000

1.0872

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale 

Number of securities

Price per unit (Note 5)

Sale

25,000

0.36 GBP

(b) Derivatives transactions (other than options)

 

Product name, e.g CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price 

Type, e.g. American, European etc.

Expiry date

Option moneypaid/received per unit (Note 5) 

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

……………………………………………………………………

……………………………………………………………………

Is a Supplemental Form 8 attached? (Note 9) NO

 

 

Date of disclosure

19 June 2008

Contact name

Barbara Menegazzi

Telephone number

020 7818 6492

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

SUPPLEMENTAL FORM 8

 

 

DETAILS OF OPEN POSITIONS 

(This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

 

 

 

OPEN POSITIONS (Note 1)

 

Product name,e.g. call option

 

Written or purchased

 

Number of securities to which the option or derivative relates

Exercise price (Note 2)

 

Type, e.g. American, European etc.

Expiry date

 

Notes

 

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form.

 

2. For all prices and other monetary amounts, the currency must be stated.

 

For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETEAEKNFDLPEFE
Date   Source Headline
31st Mar 20063:54 pmRNSBoard Change
31st Mar 20063:52 pmRNSHolding(s) in Company
29th Mar 200611:45 amRNSEGM Statement
29th Mar 20067:02 amRNSNew Venture Company
6th Mar 20067:02 amRNSPlacing
24th Jan 20067:01 amRNSChange of Adviser
24th Jan 20067:01 amRNSInterim Results
24th Jan 20067:01 amRNSContract Extension
16th Dec 20052:32 pmRNSSnr Appt at Geomerics
17th Nov 20057:02 amRNSRe US Venture -- Aberro
15th Nov 20057:03 amRNSRe Synature Ltd
11th Nov 20057:29 amRNSAppointment at Novocellus Ltd
2nd Nov 20059:41 amRNSDirector/PDMR Shareholding
25th Oct 20058:00 amRNSAppointments - UK Ventures
20th Oct 20057:00 amRNSContract Extension
17th Oct 20057:01 amRNSVentures (US) Team Expansion
1st Sep 200512:43 pmRNSHolding(s) in Company
25th Aug 20053:02 pmRNSResult of AGM
11th Aug 20055:21 pmRNSAdditional Listing
1st Aug 20057:01 amRNSDirectorate Change
20th Jul 20058:30 amRNSContract Win
6th Jul 20057:01 amRNSFinal Results
24th Jun 20058:00 amRNSRe Provexis Admission to AIM
23rd Jun 20053:13 pmRNSNotice of Results
22nd Jun 200512:45 pmRNSHolding(s) in Company
10th Jun 20057:01 amRNSJoint Research Programme
31st May 20057:02 amRNSRe Acolyte Biomedica
26th May 20057:02 amRNSTrading Update
26th May 20057:02 amRNSProvexis - Reverse Takeover
6th May 20057:00 amRNSGeomerics - New Venture Co.
29th Apr 20057:01 amRNSNew US Venture
12th Apr 20057:00 amRNSNew Contracts
23rd Mar 200512:03 pmRNSRe Provexis Limited
21st Mar 20058:51 amRNSAdditional Listing
10th Mar 200512:06 pmRNSDirector Appt to UK Ventures
18th Feb 20058:52 amRNSProvexis Reverse Takeover
11th Feb 20057:00 amRNSNew Venture Company
10th Feb 20051:30 pmRNSHolding(s) in Company
20th Jan 20057:01 amRNSNew Agreement
20th Jan 20057:00 amRNSInterim Results
18th Jan 20057:00 amRNSLaunch of US Ventures
17th Jan 200510:47 amRNSAssociate Director Appointed
7th Jan 200510:44 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.